Related Experiment Video
Updated: Jan 11, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
ET occurring in NPM1-mutated AML during molecular complete remission: A further potential evolution of a complex
Diego Bertoli1, Carlotta Giupponi1,2, Giuseppe Rossi2
1Highly Specialized Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy.
Abstract:
Nucleophosmin 1 (NPM1)mut acute myeloid leukaemia (AML) patients may experience different disease evolutions after achieving complete remission. Essential thrombocythaemia (ET) may arise in ≈3% of NPM1mutAML patients achieving molecular remission after treatment. The presence of JAK2V617F mutation within the persisting clonal haematopoietic background of NPM1mutAML favours the development of ET among other myeloid malignancies during NPM1wtAML remission.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
Spontaneous and Induced Mutations
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

